Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients
- 1 April 2004
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 72 (5) , 307-313
Abstract
Background: The FLT3 gene is frequently mutated in acute myeloid leukemia (AML), either by an internal tandem duplication (ITD) of the juxtamembrane domain or by activating point mutations in the second tyrosine kinase domain (ATKD). Only a few investigations have focused on the prognostic significance of FLT3 alterations in AML among the elderly, yielding conflicting results. In the present study, the frequency and clinical relevance of FLT3 abnormalities were ascertained in a cohort of elderly AML patients.Patients and methods: A total of 109 AMLs, occurring in patients above the age of 60 yr (median 71.5), were investigated. DNA was extracted from fresh bone marrow cells or from cells in fixative and investigated for the presence of ITD of exons 14 and 15 and the ATKD D835 in exon 20.Results: ITDs and ATKDs were identified in 20 (18%) and 11 (10%) of the cases, respectively. Three cases displayed both an ITD and an ATKD. FLT3 abnormalities were associated with leukocytosis (ITD P < 0.01; ATKD P = 0.069), and the monocytic FAB subtypes M4 and M5 [ITD (P < 0.05), ATKD (P = 0.05)], and ITD and ATKD were significantly (P < 0.05) more common in cases with a normal karyotype. There was no correlation between the presence of FLT3 abnormalities and complete remission rates or overall survival.Conclusion: A correlation was observed between FLT3 abnormalities and leukocytosis, a normal karyotype, and the M4/M5 subtypes of leukemia. However, no clear‐cut prognostic impact of FLT3 abnormalities was identified in elderly AML patients.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic significance of FLT3 ITD and D835 mutations in AML patientsThe Hematology Journal, 2003
- Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmBlood, 2002
- A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaBlood, 2002
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Improved outcome in adult acute myeloid leukemia is almost entirely restricted to young patients and associated with stem cell transplantationEuropean Journal of Haematology, 2002
- Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemiaBritish Journal of Haematology, 2001
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesBlood, 2001
- Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patientsBritish Journal of Haematology, 2001
- Survival time in a population-based consecutive series of adult acute myeloid leukemia – the prognostic impact of karyotype during the time period 1976–1993Leukemia, 2000
- Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemiaLeukemia, 1997